NERV logo

Minerva Neurosciences, Inc.

NERV
Healthcare|Biotechnology|US
$2.42
+0.12 (+5.22%)
DCF Value
$1.98
Cash / Share
$1.56
Next Earnings Report
Mar 10, 2027
EPS est. -$0.09
Financing Filings (last 12 months)
4
Shelf registrations / offering prospectuses — latest May 27, 2026 (424B5). Possible dilution.

Upcoming Data Readouts (1)

Dec 2027
Est. completion
P3Negative Symptoms of Schizophrenia
Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications
NCT07565428n=380

Recent Press Releases

Minerva Neurosciences Provides Third Quarter 2026 Financial Results and Business Updates
Nov 6, 2026 · GlobeNewsWire
Minerva Neurosciences to Participate in 2026 Jefferies Global Healthcare Conference in London
Oct 29, 2026 · GlobeNewsWire
Minerva Neurosciences to Host In-Person KOL Event to Discuss Roluperidone for Negative Symptoms of Schizophrenia
Oct 28, 2026 · GlobeNewsWire
Minerva Neurosciences to Participate in Two Upcoming Investor Conferences
Aug 28, 2026 · GlobeNewsWire

SEC Filings (57)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 6, 202610-QQuarterly reportDocumentIndex
Nov 6, 20268-KMaterial eventDocumentIndex
Oct 27, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 13, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 12, 20268-KMaterial eventDocumentIndex
Aug 7, 202610-QQuarterly reportDocumentIndex
Aug 7, 20268-KMaterial eventDocumentIndex
Jul 8, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jun 4, 20268-KMaterial eventDocumentIndex
May 27, 20268-KMaterial eventDocumentIndex
May 27, 2026424B5Offering prospectusDocumentIndex
May 15, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 5, 202610-QQuarterly reportDocumentIndex
May 5, 20268-KMaterial eventDocumentIndex
Apr 23, 2026ARSAnnual report to holdersDocumentIndex
Apr 23, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 23, 2026DEF 14AProxy / shareholder voteDocumentIndex
Apr 10, 2026PRE 14AProxy / shareholder voteDocumentIndex
Apr 6, 20268-KMaterial eventDocumentIndex
Apr 2, 20268-KMaterial eventDocumentIndex
Mar 19, 2026EFFECTDocumentIndex
Mar 11, 2026S-3Shelf registrationDocumentIndex
Mar 11, 202610-KAnnual reportDocumentIndex
Mar 11, 20268-KMaterial eventDocumentIndex
Feb 20, 2026SC 13GPassive 5%+ stakeDocumentIndex
Feb 17, 2026SC 13GPassive 5%+ stakeDocumentIndex
Feb 17, 2026SC 13GPassive 5%+ stakeDocumentIndex
Feb 12, 2026SC 13GPassive 5%+ stakeDocumentIndex
Feb 5, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 3, 20268-KMaterial eventDocumentIndex
Jan 6, 2026EFFECTDocumentIndex
Jan 6, 2026424B3Offering prospectusDocumentIndex
Dec 31, 2025SC 13GPassive 5%+ stakeDocumentIndex
Dec 30, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Dec 29, 2025SC 13GPassive 5%+ stakeDocumentIndex
Dec 29, 2025SC 13GPassive 5%+ stakeDocumentIndex
Dec 23, 2025S-8Employee stock planDocumentIndex
Dec 23, 2025S-3Shelf registrationDocumentIndex